Two cases of critically ill patients who received extracorporeal membrane oxygenation (ECMO) using different forms of circuitry and for different indications are presented. Both patients had life-threatening infections with septic shock and were not able to be supported by conventional means. The first patient had staphylococcal septicaemia and received venoarterial ECMO for circulatory failure. The second patient had psittacosis and received venovenous ECMO for respiratory failure. We discuss the expanding indications for this technology and the role it has to play in adult intensive care.
Extracorporeal membrane oxygenation (ECMO) is a controversial mode of cardiopulmonary support in adult intensive care units (ICU). We present two cases of patients with severe infections that illustrate the life-sustaining capabilities of ECMO in this condition when it is applied appropriately.
CASE HISTORIES Patient 1
A 22-year-old, previously well patient presented to our hospital following a domestic accident. He sustained a closed head injury with cerebral contusion and a small traumatic subarachnoid haemorrhage in addition to a Chance fracture of his ninth thoracic vertebra. He was taken to the operating theatre and underwent operative fixation of the fracture using titanium prostheses. He made a complete recovery and was discharged home.
The patient was readmitted one week after discharge with abdominal pain and fever (40°C). His pulse rate was 110 beats per minute (bpm) and his mean arterial pressure (MAP) was 69 mmHg. On examination, there were no focal neurological deficits and his abdomen and back were not tender to palpation. A computerized tomography (CT) scan of his abdomen and lower thoracic spine was unremarkable. An ultrasound of his back did not demonstrate any collection. Blood cultures were taken and he was given intravenous fluids, vancomycin and ceftriaxone. A magnetic resonance image (MRI) of his lower thoracic vertebrae was booked for the following day to better assess for possible osteomyelitis associated with the prostheses.
Later that evening, the patient became hypotensive (MAP 55 mmHg) and was admitted to the ICU. Despite further fluid resuscitation, he deteriorated overnight, becoming more hypotensive (MAP 50 mmHg), tachypnoeic (respiratory rate (RR) 40), hypoxic (SpO 2 88%), and acidotic (pH 7.25). He was intubated and commenced on noradrenaline. A pulmonary artery catheter was inserted and the patient's cardiac output was measured, confirming a pattern of distributive shock with a cardiac index of 5.6 l.min -1. m -2 , a systemic vascular resistance index of 500 dyn.s.m -2 .cm -5 , and a pulmonary artery occlusion pressure of 15 mmHg. A transoesophageal echocardiogram (TOE) showed dilated left and right ven-tricles with global hypokinesis and an estimated ejection fraction of 30 to 35%, consistent with severe sepsis. He was started on intravenous hydrocortisone at 10 mg/h. The use of activated protein C was discounted because of his recent head injury.
Within eighteen hours of presentation, the patient had developed profound shock that was refractory to conventional support. Despite considerable fluid resuscitation (6 litres of crystalloid and 2.5 litres of colloid since admission), 50 µg/min noradrenaline, 30 µg/min adrenaline and 3 U/h vasopressin, his MAP remained less than 60 mmHg, he had a worsening metabolic acidosis (pH 7.13) and he was having recurrent episodes of unsustained ventricular tachycardia. A repeat TOE showed further dilatation of both ventricles and a decrease in the ejection fraction. His cardiac index measured by thermodilution had fallen to 3.0 l/min/m 2 . A diagnosis of fulminant sepsisinduced myocardial depression was made. The patient was then taken to theatre where he was placed on venoarterial ECMO by femoro-femoral cannulation, achieving flows of 5 l/min.
On arrival back in ICU, he was acidotic with an arterial pH 6.9. Continuous venovenous haemodiafiltration was commenced. His adrenaline was tapered off and replaced with dobutamine in an attempt to help resolve the acidosis. Over the several hours following the establishment of ECMO, he improved haemodynamically, his vasopressin and noradrenaline infusions were weaned successfully and his acidosis resolved.
The next day it was confirmed that methicillinsensitive Staphylococcus aureus was growing in multiple blood cultures and wound swabs. His vancomycin and ceftriaxone were replaced with flucloxacillin and rifampicin. The patient's spinal prostheses were presumed to be the source of infection. He was reviewed by his neurosurgeon, who felt that removal of any graft material at this time would carry an unacceptably high risk of paraplegia.
The patient remained stable on ECMO and dobutamine and made a slow recovery. His ECMO cannulae were removed one week after insertion. His inotropes were stopped and he was weaned from mechanical ventilation with the aid of a tracheostomy. Thirty-five days after admission he was discharged from ICU, leaving hospital eleven days later.
Nearly one year after this illness, whilst the patient still has abnormal cardiac function (ejection fraction 35% on echocardiography), he is steadily improving with treatment and can walk up four flights of stairs without dyspnoea. He remains on long-term suppres-sive oral flucloxacillin and is being considered for removal of his spinal prosthetic material in the near future.
Patient 2
A 46-year-old woman with an unremarkable past history presented to our hospital with a seven-day history of diarrhoea and a twelve-hour history of dry cough and worsening dyspnoea. She was profoundly hypoxic and required immediate intubation. She was ventilated with synchronised intermittent mandatory ventilation (SIMV) with 8 ml/kg tidal volumes and 10 cmH 2 O positive end-expiratory pressure (PEEP). Her temperature was 38.7°C. A chest radiograph showed bibasal consolidation with air bronchograms. Other preliminary investigations showed evidence of multiorgan failure with impaired renal function (serum urea 23.7 mmol/l, creatinine 0.20 mmol/l), myocardial dysfunction (troponin I 68.8 µg/l), neutrophilia (12.4 x 10 9 /l), and clotting abnormalities (INR 1.8). Her erythrocyte sedimentation rate was 94 mm/h and C-reactive protein 650 mg/l. Multiple blood cultures were sent and she was given ceftriaxone, ciprofloxacin and rifampicin. She required fluid resuscitation and 4 µg/min noradrenaline to maintain a MAP of greater than 70 mmHg. A provisional diagnosis of community-acquired pneumonia with septic shock and acute respiratory distress syndrome (ARDS) was made.
By twenty-four hours after presentation, the patient's gas exchange had deteriorated further. Despite 15 cmH 2 O PEEP and 40 ppm nitric oxide, her P a O 2 /FiO 2 (P/F) ratio was 57. Prone positioning was tried without significant improvement in gas exchange. A frusemide infusion was commenced at 40 mg/h and titrated to provide a urine output of 100 ml/h without any change in her vasopressor requirements. The ceftriaxone was changed to meropenem to broaden her antibiotic cover.
By the next day, her P/F ratio was 44, despite 20 cmH 2 O PEEP and nitric oxide, and it was decided to commence ECMO. A TOE showed hyperdynamic ventricles, confirming that venovenous cannulation was appropriate. Two femoral ECMO cannulae were placed percutaneously by the ICU consultant. Venovenous flows of 2.5 l/min were established, the patient's P a O 2 improved immediately to 128 mmHg, and her FiO 2 was able to be lowered.
She remained critically ill but stable on venovenous ECMO over the next six days. Her ECMO flows were limited to 2.5 l/min, providing her with SpO 2 80 -88%. Her haemoglobin was kept above 100 g/l to maximize oxygen delivery. The ventilator (Bennett 840, Puritan Bennett Corporation, Carlsbad, Ca, U.S.A.) was set in BiLevel mode, alternating between a PEEP of 15 and 35 cmH 2 O, with a RR 8 and FiO 2 0.6. Tidal volumes between 75 and 100 ml were achieved. During this time, she developed distal ischaemia in several digits of her left hand and both feet, despite no longer receiving inotropes and having patent large feeding vessels on ultrasound examination.
All microbiological testing had been unhelpful up to this point, including microscopy and culture of bronchoalveolar lavage fluid, and urinary antigen for Legionella. A thoracic CT scan showed dense, uniform bilateral consolidation from the bases to the apices. An open-lung biopsy was not diagnostic, showing diffuse alveolar damage with a neutrophilic infiltrate suggestive of parenchymal infection. All microbiological tests on the lung specimen, including conventional microscopy and culture, in addition to those for acid-fast bacilli, fungi, Pneumocystis carinii and viruses, were negative.
The patient started to improve fourteen days after initiation of ECMO. Over the course of several days her pulmonary infiltrates resolved and her gas exchange improved to the point that her ECMO could be weaned and the cannulae removed after nineteen days of extracorporeal support. A polymerase chain reaction for Chlamydia psittaci from a left lower lobe bronchoalveolar washing was positive and her convalescent serology later showed a rise in titre consistent with psittacosis.
The rest of her ICU stay was uncomplicated. Her ischaemic digits demarcated with minimal tissue loss and she was weaned from the ventilator with the aid of a tracheostomy. Sixty-two days after admission to hospital, she was discharged to a rehabilitation centre, where she is currently making a good recovery.
DISCUSSION
Following the publication of two prospective, randomized trials of ECMO in adult respiratory failure several years ago 1,2 , ECMO was discounted as effective therapy by many clinicians. However, a number of changes have occurred since these trials that necessitate a reappraisal of the role of ECMO in adult ICU. Most importantly, the extracorporeal circuitry that was used in both trials has been superseded by more advanced technology. The development of newer centrifugal pumps, polymethyl pentene oxygenators 3 and heparin-bonded circuits have considerably reduced the complications of ECMO, to the point that it is now possible to successfully perform complex neurovascular surgery on patients receiving ECMO without major haemorrhage 4 . A number of centres now report survival rates in uncontrolled series of patients with severe respiratory failure of over 50% [5] [6] [7] [8] . Furthermore, ECMO is being applied successfully for a wide variety of other indications, such as during cardiac arrest 9,10 , the transport of critically ill patients 11, 12 and in post-cardiotomy shock 13 .
The two cases presented illustrate the successful application of ECMO in patients with septic shock. Historically, septic shock was seen as a contraindica- tion to ECMO 14 but it is apparent that this is not true. The first patient had staphylococcal septicaemia and received venoarterial ECMO to overcome sepsisinduced myocardial depression. The second patient with psittacosis maintained a hyperdynamic circulation and thus received venovenous ECMO to maintain adequate oxygenation for severe ARDS. Neither patient suffered a complication from ECMO in a cumulative total of twenty-six days of extracorporeal support. ECMO does not reverse septic shock but rather enables support of patients with otherwise fatal cardiac or pulmonary disease, until they either overcome the underlying infection or succumb to the complications of ECMO.
In 2003 the Alfred Hospital Intensive Care Unit used ECMO in eighteen adult patients with a wide variety of conditions who were unsupportable by conventional means ( Table 1 ). Of these, ten survived (55.6%), a survival rate very similar to other series 5, 8 . This has been achieved by utilizing the new pumps and circuitry now available, by having the ECMO service run by the intensive care specialists with technical assistance from the Department of Perfusion, and providing ECMO education workshops for the nursing staff and registrars.
ECMO is a means of providing support to patients who would otherwise die. It is unlikely that high level evidence supporting this technique will appear in the near future. The difficulties of conducting prospective trials involving ECMO for patients in extremis have been discussed elsewhere 5 . We recommend that ECMO should be used in patients with potentially reversible illnesses who are unsupportable by other means. Its use should be confined to centres that have sufficient experience to apply it safely.
